Trial intelligence / Profile preview

Vonoprazan vs Lansoprazole in Erosive Esophagitis

NCT01452698Phase 3Completed

Sponsor
Takeda
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vonoprazan in erosive esophagitis (EE), sponsored by Takeda. Status: completed.

02

Drugs

vonoprazan
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT01452698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01452698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call